The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

Abstract

Key Points The K666N mutation of SF3B1 has distinct clinicopathologic features in MDS. The K666N mutation of SF3B1 has a distinct RNA splicing profile.